Sigyn Therapeutics, Inc. (SIGY)

Price$0.0290Cached quote
SIGYOTC
Loading local price history

Financial charts

Revenue

Net income

Total cash / debt

CashTotal debt

Financial statements

10 annual periodsNewest to oldest
2024202320222021202020192018201720152014
Revenue$0$0$0$0—$143,322$28,348$38,434$29,207$43,154
Gross profit$0$0$0$0—$107,657$18,636$17,003$19,277$17,904
Gross margin—————75.12%65.74%44.24%66.00%41.49%
Research & development$773,279$798,165$657,657$734,014$419,362—————
Operating expenses$2.5M$2.5M$2.1M$2.0M$916,434$625,615$1.0M$2.0M$2.3M$405,448
Operating income−$2.5M−$2.5M−$2.1M−$2.0M−$916,434−$517,958−$1.0M−$2.0M−$2.3M−$387,544
Operating margin—————−361.39%−3,544.18%−5,277.41%−7,714.35%−898.05%
EBITDA−$2.5M−$2.4M−$2.1M−$2.0M−$905,134−$505,538−$992,005−$2.0M−$2.3M—
EBITDA margin—————−352.73%−3,499.38%−5,241.73%−7,710.39%—
Net income−$3.3M−$4.1M−$2.9M−$3.0M−$1.3M−$3.1M−$2.6M−$4.3M−$2.7M−$387,544
Net profit margin—————−2,145.30%−9,243.24%−11,061.21%−9,224.88%−898.05%
Basic EPSper basic share-$2.51-$3.77-$3.13-$3.20-$6.80-$1.60-$1.60-$3.60-$3.60-$0.40
Diluted EPSper diluted share-$2.51-$3.77-$3.13-$3.20-$6.80-$1.60-$1.60-$3.60-$3.60-$0.40

Owners

Reported shareholders

Reference date Jun 30, 2026

Reported holdings Number of shares

View holders
Top 1 reported holders of SIGY
HolderShares held
Howard Capital Management Group, LLC
53K

Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.

Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.

Community posts

It’s quiet here.

No posts about SIGY yet. Start the conversation.

Write the first post